Kioxia, StorOne, Phison And Marvell Deliver Storage And Memory For AI
Artificial Intelligence training and inference are a major factor in increasing digital storage and memory demand growth. According to a recent announcement from the Dell'Oro Group, the AI expansion cycle led to a 62% year over year growth in Q1 2025 in telecommunications, security, networks and data center industries, including memory and storage. Let's look at some recent storage announcements to support AI workloads from Kioxia, StorOne and Phison and Marvell Technologies.
Kioxia recently announced its single port CD9P Series PCIe 5.0 NVMe 2.0 SSDs built with the company's 8thgeneration BiCS Flash TLC-based 3D flash memories (with 330 layers--?). These products also incorporate the company's CMOS directly Bonded to Array technology to boost power efficiency, performance, and storage density. Images of the product family are shown below.
Kioxia CD9P SSD Product Family
According to Kioxia, the CD9P Series is purpose-built for these next-generation environments, delivering the speed and responsiveness required by AI, machine learning, and high-performance computing (HPC) workloads to ensure GPUs stay fed with data and operating at maximum efficiency. The product is available in EDSFF E3.S form factor with 1.6-30.72 TB capacities and 2.5-inch U.2 form factor with 1.6-61.44TB capacities.
The CD9P Series 15.36 TB model delivers approximately 60% and 45% improvements in sequential read and write speeds per watt, respectively, compared to the previous generation Kioxia SSD. It also achieves gains of approximately 55% and 100% in random read and write performance per watt, measured in thousands of IOPS (KIOPS), respectively. The product is being sampled to select customers and was on display at the on-going HPE Discover Las Vegas event. The table below gives more details on this model's performance with different workflows.
CD9P Performance versus Workloads
StorOne unveiled its ONEai, Automated AI Solution Optimized for Enterprise Data Storage in partnership with SSD company, Phison Electronics. StorONE integrated Phison's aiDAPTIV+ AI capabilities into the StorONE enterprise storage system to accelerate AI deployment and deliver domain specific responses on the stored data for end users.
The Prompt: Get the week's biggest AI news on the buzziest companies and boldest breakthroughs, in your inbox.You're Subscribed!
You're Subscribed!
According to StorOne, ONEai leverages AI GPU and memory optimization, intelligent data placement and built-in support for LLM inferencing and fine-tuning directly within the storage framework, offering an efficient, AI-integrated system with minimal setup complexity. With ONEai, users benefit from reduced power, operational and hardware costs, enhanced GPU performance and on-premises LLM training and inferencing on proprietary organizational data.
Marvell Technology, Inc. announced that it has expanded its custom technology platform with the launch of a 2nm custom Static Random Access Memory (SRAM), designed to boost the performance of custom XPUs and devices powering cloud data centers and AI clusters. It also introduced its Package Integrated Voltage Regulator (PIVR) power solutions, which it says enable hyperscalers to enhance the performance, efficiency and return on investment (ROI) of AI and cloud infrastructure.
This custom SRAM delivers up to 6 gigabits of high-speed memory. Marvell said that it had previously introduced its CXL technology for integration into custom silicon to add terabytes of memory and supplemental compute capacity to cloud servers and unveiled custom HBM technology that increases memory capacity by up to 33% while reducing the space and power required for dense high-bandwidth memory (HBM) stacks inside XPUs.
AI drives storage and memory demand. Kioxia, StorOne, Phison and Marvell Technologies announced digital storage and memory applications to support diverse AI workloads.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a minute ago
- Yahoo
Asian Market Value Stocks: 3 Companies Estimated Below Intrinsic Worth
As global markets navigate a complex landscape of economic indicators and policy shifts, the Asian market has shown resilience, with indices in China and Japan posting gains amid strong corporate earnings and robust trade data. In this environment, identifying undervalued stocks can be crucial for investors seeking opportunities potentially mispriced by the market; these stocks may offer intrinsic value that is not yet reflected in their current trading prices. Top 10 Undervalued Stocks Based On Cash Flows In Asia Name Current Price Fair Value (Est) Discount (Est) SRE Holdings (TSE:2980) ¥3180.00 ¥6212.44 48.8% SILICON2 (KOSDAQ:A257720) ₩53700.00 ₩105825.30 49.3% Nanya Technology (TWSE:2408) NT$43.95 NT$87.08 49.5% Jiangsu Yunyi ElectricLtd (SZSE:300304) CN¥11.08 CN¥22.02 49.7% Heartland Group Holdings (NZSE:HGH) NZ$0.80 NZ$1.58 49.5% Guangdong Marubi Biotechnology (SHSE:603983) CN¥40.73 CN¥79.39 48.7% GEM (SZSE:002340) CN¥6.54 CN¥13.00 49.7% Finger (KOSDAQ:A163730) ₩13480.00 ₩26287.68 48.7% cottaLTD (TSE:3359) ¥442.00 ¥867.58 49.1% Andes Technology (TWSE:6533) NT$276.50 NT$541.44 48.9% Click here to see the full list of 277 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Let's dive into some prime choices out of the screener. SILICON2 Overview: SILICON2 Co., Ltd. is involved in the global distribution of cosmetics products and has a market cap of approximately ₩3.52 trillion. Operations: The company generates revenue from its wholesale miscellaneous segment, amounting to ₩787.27 million. Estimated Discount To Fair Value: 49.3% SILICON2 is trading at ₩53,700, significantly below its estimated fair value of ₩105,825.3, presenting a potential undervaluation based on cash flows. Despite recent earnings volatility and high non-cash earnings, its revenue is expected to grow 20.6% annually—outpacing the Korean market's 7.2% growth rate—while profits are forecasted to increase by 20.75% per year. The company's strong first-quarter net income of KRW 38,785 million supports this outlook despite share price volatility. Our comprehensive growth report raises the possibility that SILICON2 is poised for substantial financial growth. Navigate through the intricacies of SILICON2 with our comprehensive financial health report here. Damai Entertainment Holdings Overview: Damai Entertainment Holdings Limited is an investment holding company engaged in content, technology, and IP merchandising and commercialization businesses in Hong Kong and the People's Republic of China, with a market cap of approximately HK$35.25 billion. Operations: The company's revenue segments include CN¥2.06 billion from Damai, CN¥499.92 million from Drama Series Production, CN¥1.43 billion from IP Merchandising and Innovation Initiatives, and CN¥2.71 billion from its Film Technology and Investment, Production, Promotion and Distribution Platform. Estimated Discount To Fair Value: 20.9% Damai Entertainment Holdings, trading at HK$1.18, is undervalued with a fair value estimate of HK$1.49, based on cash flow analysis. Despite recent insider selling and share price volatility, the company reported CNY 6.70 billion in sales for the year ending March 2025—up from CNY 5.03 billion—and net income increased to CNY 363.58 million. Earnings are expected to grow significantly at over 40% annually, outpacing Hong Kong market forecasts. Our earnings growth report unveils the potential for significant increases in Damai Entertainment Holdings' future results. Get an in-depth perspective on Damai Entertainment Holdings' balance sheet by reading our health report here. Accton Technology Overview: Accton Technology Corporation engages in the research, development, manufacturing, and sale of network communication equipment across Taiwan, America, Asia, Europe, and internationally with a market cap of NT$552.76 billion. Operations: Accton Technology Corporation generates revenue through its research, development, manufacturing, and sales activities in the field of network communication equipment across various regions including Taiwan, America, Asia, Europe, and other international markets. Estimated Discount To Fair Value: 37.5% Accton Technology, trading at NT$989, is undervalued with a fair value estimate of NT$1,581.54 based on cash flow analysis. Recent earnings showed significant growth with second-quarter revenue reaching TWD 60.60 billion and net income at TWD 5.03 billion. Despite high share price volatility, the company's earnings grew by 83.2% over the past year and are forecast to grow significantly at 22.8% annually, outpacing Taiwan's market expectations. The analysis detailed in our Accton Technology growth report hints at robust future financial performance. Take a closer look at Accton Technology's balance sheet health here in our report. Key Takeaways Click through to start exploring the rest of the 274 Undervalued Asian Stocks Based On Cash Flows now. Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Want To Explore Some Alternatives? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include KOSDAQ:A257720 SEHK:1060 and TWSE:2345. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
a minute ago
- Yahoo
High Growth Tech Stocks In Asia For August 2025
Amidst a backdrop of global economic shifts, the Asian markets have been experiencing notable developments, with China's robust export data and Japan's positive investor sentiment driving regional optimism. In this environment, high-growth tech stocks in Asia are gaining attention as investors seek opportunities that align with the current market dynamics and demonstrate resilience in adapting to evolving trade policies and economic conditions. Top 10 High Growth Tech Companies In Asia Name Revenue Growth Earnings Growth Growth Rating Accton Technology 22.79% 22.79% ★★★★★★ Shanghai Huace Navigation Technology 25.19% 23.94% ★★★★★★ Zhejiang Lante Optics 21.61% 23.73% ★★★★★★ PharmaEssentia 31.60% 57.71% ★★★★★★ Fositek 31.44% 38.26% ★★★★★★ Eoptolink Technology 32.53% 32.58% ★★★★★★ Gold Circuit Electronics 26.46% 31.77% ★★★★★★ Shengyi Electronics 26.23% 37.08% ★★★★★★ eWeLLLtd 24.95% 24.40% ★★★★★★ CARsgen Therapeutics Holdings 81.53% 96.08% ★★★★★★ Click here to see the full list of 171 stocks from our Asian High Growth Tech and AI Stocks screener. Let's dive into some prime choices out of from the screener. Rigol Technologies Simply Wall St Growth Rating: ★★★★☆☆ Overview: Rigol Technologies Co., Ltd. is a global manufacturer and seller of test and measurement instruments, with a market capitalization of approximately CN¥6.96 billion. Operations: The company generates revenue primarily from its electronic test and measurement instruments segment, which accounts for CN¥792.64 million. Rigol Technologies, amidst a dynamic tech landscape, demonstrates robust potential with its earnings projected to surge by 30.4% annually, outpacing the broader Chinese market's 23.6%. This growth is underpinned by significant R&D investments that reflect the company's commitment to innovation and maintaining a competitive edge in electronic technologies. However, it faces challenges as its revenue growth at 16.8% lags behind the high-growth threshold of 20%, coupled with a recent dip in earnings by -1.5% over the past year compared to the industry average of 2.8%. Looking ahead, while Rigol grapples with these mixed financial signals and one-off gains impacting earnings quality, its strategic focus on R&D could catalyze future advancements and market positioning in Asia's tech sector. Dive into the specifics of Rigol Technologies here with our thorough health report. Gain insights into Rigol Technologies' past trends and performance with our Past report. Shenzhen Newway Photomask Making Simply Wall St Growth Rating: ★★★★★☆ Overview: Shenzhen Newway Photomask Making Co., Ltd is a lithography company focused on designing, developing, and producing mask products in China with a market capitalization of approximately CN¥7.13 billion. Operations: Shenzhen Newway Photomask Making Co., Ltd derives its revenue primarily from the electronic components and parts segment, generating approximately CN¥958.81 million. The company operates within the lithography sector, focusing on mask product design and production in China. Shenzhen Newway Photomask Making, a player in the high-growth tech sector in Asia, is making significant strides with its robust revenue growth of 27.1% annually, outperforming the broader Chinese market's average of 12.6%. This growth is bolstered by an impressive earnings increase projected at 33% per year, reflecting strong operational efficiency and market demand. The company has committed heavily to innovation with substantial R&D investments that represent a strategic move to solidify its competitive edge in the photomask industry—a critical component for semiconductor manufacturing. With recent earnings calls highlighting these advancements and a clear trajectory for future growth, Shenzhen Newway's focus on technological development positions it well amidst Asia's dynamic tech landscape. Navigate through the intricacies of Shenzhen Newway Photomask Making with our comprehensive health report here. Explore historical data to track Shenzhen Newway Photomask Making's performance over time in our Past section. Asia Vital Components Simply Wall St Growth Rating: ★★★★★★ Overview: Asia Vital Components Co., Ltd. and its subsidiaries specialize in providing thermal solutions globally, with a market capitalization of approximately NT$423.10 billion. Operations: The company generates revenue primarily through its Overseas Operating Department, contributing NT$93.10 billion, and the Integrated Management Division, adding NT$62.02 billion. Asia Vital Components has demonstrated a robust trajectory in the tech sector, with its latest quarterly earnings surging to TWD 23.33 billion, a significant leap from TWD 15.31 billion year-over-year. This performance is anchored by a net income growth to TWD 3.51 billion from TWD 1.75 billion, reflecting an earnings increase of approximately 100%. The company's aggressive expansion into Vietnam through the establishment of AVC Development Co., Ltd., underlines its strategic intent to broaden its market reach and enhance operational capacities in Southeast Asia. These moves are complemented by active participation in major industry forums across Asia and the U.S., signaling AVC's commitment to maintaining a prominent presence on the global tech stage. Get an in-depth perspective on Asia Vital Components' performance by reading our health report here. Review our historical performance report to gain insights into Asia Vital Components''s past performance. Turning Ideas Into Actions Unlock more gems! Our Asian High Growth Tech and AI Stocks screener has unearthed 168 more companies for you to here to unveil our expertly curated list of 171 Asian High Growth Tech and AI Stocks. Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly. Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide. Seeking Other Investments? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SHSE:688337 SHSE:688401 and TWSE:3017. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
a minute ago
- Yahoo
Undiscovered Gems in Asia to Explore This August 2025
As global markets navigate a complex landscape with shifting trade policies and interest rate adjustments, the Asian market stands out with its resilience, particularly in the face of U.S.-China trade dynamics. In this environment, identifying stocks that demonstrate robust growth potential and adaptability can be crucial for investors seeking to capitalize on emerging opportunities. Top 10 Undiscovered Gems With Strong Fundamentals In Asia Name Debt To Equity Revenue Growth Earnings Growth Health Rating DoshishaLtd NA 2.88% 2.08% ★★★★★★ CHT Security NA 11.39% 23.71% ★★★★★★ Kung Sing Engineering 13.45% 2.65% -51.67% ★★★★★★ FDK 89.05% 1.03% -12.00% ★★★★★☆ Uniplus Electronics 32.17% 46.30% 75.33% ★★★★★☆ Hunan Investment GroupLtd 4.50% 25.84% 15.32% ★★★★★☆ Nippon Ski Resort DevelopmentLtd 40.68% 13.17% 53.25% ★★★★★☆ BIOBIJOULtd 6.87% 72.99% 117.16% ★★★★★☆ Bank of Iwate 87.84% 1.47% 13.86% ★★★★☆☆ Lucky Cement 61.41% 4.55% 15.65% ★★★★☆☆ Click here to see the full list of 2533 stocks from our Asian Undiscovered Gems With Strong Fundamentals screener. Let's review some notable picks from our screened stocks. Shaanxi Sirui Advanced Materials Simply Wall St Value Rating: ★★★★☆☆ Overview: Shaanxi Sirui Advanced Materials Co., Ltd. operates in the advanced materials sector and has a market capitalization of approximately CN¥12.07 billion. Operations: The company generates revenue primarily from its advanced materials segment. It has a market capitalization of approximately CN¥12.07 billion, reflecting its scale in the sector. Shaanxi Sirui Advanced Materials, a smaller player in the metals and mining sector, showcases robust earnings growth of 20.5% over the past year, outpacing the industry average of -4.1%. The company's interest payments are comfortably covered by EBIT at 10x, indicating strong financial health despite a high net debt to equity ratio of 61%. While free cash flow remains negative with recent figures showing -A$153 million as of September 2024, there's potential for improvement given its forecasted annual earnings growth rate of nearly 30%. A recent shareholder meeting signals active engagement with stakeholders amid volatile share prices. Take a closer look at Shaanxi Sirui Advanced Materials' potential here in our health report. Explore historical data to track Shaanxi Sirui Advanced Materials' performance over time in our Past section. Cre8 Direct (NingBo) Simply Wall St Value Rating: ★★★★★☆ Overview: Cre8 Direct (NingBo) Co., Ltd. is a company that, along with its subsidiaries, focuses on designing, producing, processing, and selling paper products in North America and has a market capitalization of CN¥5.54 billion. Operations: Cre8 Direct generates revenue primarily from the sale of paper products, totaling CN¥2.07 billion. The company's financial performance is influenced by its ability to manage production costs and optimize profit margins in a competitive market. Cre8 Direct (NingBo) has demonstrated robust financial health with earnings surging by 31% over the past year, significantly outpacing the Forestry industry's -6.9%. The company enjoys a strong position with cash exceeding total debt, ensuring an appropriate debt level. Its interest payments are comfortably covered by EBIT at 239 times, highlighting solid financial management. Despite recent share price volatility, Cre8 Direct continues to deliver high-quality earnings and positive free cash flow. A recent dividend approval of CNY 1.50 per 10 shares underscores its commitment to shareholder returns while maintaining growth momentum in the competitive landscape. Navigate through the intricacies of Cre8 Direct (NingBo) with our comprehensive health report here. Evaluate Cre8 Direct (NingBo)'s historical performance by accessing our past performance report. Sanbo Hospital Management Group Simply Wall St Value Rating: ★★★★★☆ Overview: Sanbo Hospital Management Group Limited, along with its subsidiaries, specializes in hospital management in China and has a market capitalization of CN¥11.69 billion. Operations: Sanbo Hospital Management Group generates revenue primarily from its healthcare facilities and services, amounting to CN¥1.49 billion. The company's financial performance is highlighted by a net profit margin that reflects its operational efficiency within the hospital management sector in China. Sanbo Hospital Management Group, a small player in the healthcare sector, showcases impressive financial resilience. Its earnings growth of 26% over the past year outpaces the industry average of -9%, highlighting robust performance. Despite an increase in its debt to equity ratio from 3% to 7.4% over five years, Sanbo holds more cash than total debt, suggesting sound financial health. Interest payments are well covered by EBIT at a substantial 257 times coverage. The company recently approved a final cash dividend of CNY1.48 per ten shares, indicating confidence in its profitability and future prospects within the healthcare landscape. Dive into the specifics of Sanbo Hospital Management Group here with our thorough health report. Gain insights into Sanbo Hospital Management Group's historical performance by reviewing our past performance report. Make It Happen Click here to access our complete index of 2533 Asian Undiscovered Gems With Strong Fundamentals. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Seeking Other Investments? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SHSE:688102 SZSE:300703 and SZSE:301293. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
